|
|
8-K |
Report of unscheduled material events or corporate event
|
Intellia Therapeutics, Inc. |
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
View HTML |
|
|
10-Q |
Quarterly report which provides a continuing view of a company's financial position
|
Intellia Therapeutics, Inc. |
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
View HTML |
|
|
8-K |
Report of unscheduled material events or corporate event
|
Intellia Therapeutics, Inc. |
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
View HTML |
|
|
DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy")
|
Intellia Therapeutics, Inc. |
View HTML |
|
|
DEFA14A |
Additional proxy soliciting materials - definitive
|
Intellia Therapeutics, Inc. |
View HTML |
|
|
3 |
Initial filing by director officer or owner of more than ten percent.
|
Intellia Therapeutics, Inc. |
View HTML |
|
|
4 |
Statement of changes in beneficial ownership of securities
|
Intellia Therapeutics, Inc. |
View HTML |
|
|
4/A |
Amendment to a previously filed 4
|
Intellia Therapeutics, Inc. |
View HTML |
|
|
3 |
Initial filing by director officer or owner of more than ten percent.
|
Intellia Therapeutics, Inc. |
View HTML |
|
|
4 |
Statement of changes in beneficial ownership of securities
|
Intellia Therapeutics, Inc. |
View HTML |
